研究论文

1,2,3-三氮唑[4,5-d]嘧啶衍生物的合成及抗肿瘤活性评价

  • 栗娜 ,
  • 辛景超 ,
  • 马启胜 ,
  • 李二冬 ,
  • 孟娅琪 ,
  • 包崇男 ,
  • 杨鹏 ,
  • 宋攀攀 ,
  • 崔飞 ,
  • 陈鹏举 ,
  • 顾一飞 ,
  • 赵培荣 ,
  • 可钰 ,
  • 刘宏民 ,
  • 张秋荣
展开
  • a 郑州大学药学院 郑州 450001;
    b 新药创制与药物安全性评价 河南省协同创新中心 郑州 450001

收稿日期: 2017-09-19

  修回日期: 2017-10-25

  网络出版日期: 2017-11-17

基金资助

国家自然科学基金(No.81430085)和郑州市科技局科研(No.141PQYJS554)资助项目.

Synthesis and Antitumor Activities of Novel 1,2,3-Triazolo[4,5-d]pyrimidine Derivatives

  • Li Na ,
  • Xin Jingchao ,
  • Ma Qisheng ,
  • Li Erdong ,
  • Meng Yaqi ,
  • Bao Chongnan ,
  • Yang Peng ,
  • Song Panpan ,
  • Cui Fei ,
  • Cheng Pengju ,
  • Gu Yifei ,
  • Zhao Peirong ,
  • Ke Yu ,
  • Liu Hongmin ,
  • Zhang Qiurong
Expand
  • a School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001;
    b Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou 450001

Received date: 2017-09-19

  Revised date: 2017-10-25

  Online published: 2017-11-17

Supported by

Project supported by the National Natural Science Foundation of China (No. 81430085)and the Research Project of Science and Technology Bureau of Zhengzhou City (No.141PQYJS554).

摘要

为了寻找高效的抗肿瘤药物,设计并合成了一系列新型的1,2,3-三氮唑[4,5-d]嘧啶类衍生物,对这些化合物在人类五种癌细胞MGC-803(人胃癌细胞)、MCF-7(人乳腺癌细胞)、EC-109(人食管癌细胞)、PC-3(人前列腺癌细胞)、Hela(人宫颈癌细胞)进行抗肿瘤活性评价,结果显示大部分化合物具有较好的抗肿瘤活性,其中5-(((1H-苯并[d]咪唑-2-基)甲基)硫基)-3-苄基-N-(4-氯苯基)-3H-[1,2,3]-三氮唑[4,5-d]嘧啶-7-胺(11b)和2,2'-((5-(((1H-苯并[d]咪唑-2-基)甲基)硫基)-3-苄基-3H-[1,2,3]-三氮唑[4,5-d]嘧啶-7-基)氮烷二基)双(乙烷-1-醇)(11m)对MGC-803和Hela癌细胞的抗肿瘤活性优于对照品氟尿嘧啶.

本文引用格式

栗娜 , 辛景超 , 马启胜 , 李二冬 , 孟娅琪 , 包崇男 , 杨鹏 , 宋攀攀 , 崔飞 , 陈鹏举 , 顾一飞 , 赵培荣 , 可钰 , 刘宏民 , 张秋荣 . 1,2,3-三氮唑[4,5-d]嘧啶衍生物的合成及抗肿瘤活性评价[J]. 有机化学, 2018 , 38(3) : 665 -671 . DOI: 10.6023/cjoc201709030

Abstract

In order to find more efficient and economical antitumor drugs, a series of novel 1,2,3-triazolo[4,5-d]pyrimidine derivatives were synthesized and evaluated for their antitumor activities against five human cancer cell lines (MGC-803, MCF-7, EC-109, PC-3 and Hela) in vitro. The results showed that most compounds had good antitumor activities, especially 5-(((1H-benzo[d]imidazol-2-yl)methyl)thio)-3-bezyl-N-(4-chlorophenyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine (11b) and 2,2'-((5-(((1H-benzo[d]imidazol-2-yl)methyl)thio)-3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)azanediyl)bis(ethan-1-ol) (11m) exhibited better antitumor activities than 5-fluorouracil against MGC-803 and Hela.

参考文献

[1] Christoph, D. M.; Venkatesam, A. M.; Santos, E. D. J. Med. Chem. 2010, 53, 798.
[2] Li, Z. H.; Liu, X. Q.; Geng, P. F.; Suo, F. Z.; Ma, J. L. ACS Med. Chem. Lett. 2017, 8, 384.
[3] Yu, W. Q.; Goddard, C.; Clearfield, E.; Mills, C.; Xiao, T.; Guo, H. T.; Morrey, J. D.; Motter, N. E.; Zhao, K.; Block, T. M.; Cuconati, A.; Xu, X. D. J. Med. Chem. 2011, 54, 5660.
[4] Alper, S.; Arpaci, O. T.; Esin, A. S.; Yalcin, I. Farmaco 2002, 58, 497.
[5] Zhou, R.; Skibo, E. B. J. Med. Chem. 1996, 39, 4321.
[6] Zhou, W.; Li, H. B.; Xia, C. N.; Zheng, X. M.; Hu, W. X. Bioorg. Med. Chem. Lett. 2009, 19, 1861.
[7] Schulz, W. G.; Islam, I.; Skibo, E. B. J. Med. Chem. 1995, 38, 109.
[8] Schulz, W. G.; Nieman, R. A.; Skibo, E. B. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 11854.
[9] Skibo, E. B.; Islam, I.; Heileman, M. J.; Schulz, W. G. J. Med. Chem. 1994, 37, 78.
[10] El-Sayed, W. A.; Ali, O. M.; Faheem, M. S.; Zied, I. F.; Ab-del-Rahmanb, A. A. H. J. Heterocycl. Chem. 2012, 49, 607.
[11] Rangarajan, M.; Kim, J. S.; Jin, S.; Sim, S. P.; Liu, A.; Pilch, D. S.; Liu, L. F.; LaVoie, E. J. Bioorg. Med. Chem. 2000, 8, 1371.
[12] Andrzejewska, M.; Yepez-Mulia, L.; Tapia, A.; Cedillo-Rivera, R.; Laudy, A. E.; Starosciak, B. J.; Kazimierczuk, Z. Eur. J. Pharm. Sci. 2003, 21, 323.
[13] Chen, J. Y.; Ren, X. X.; Mao, Z. W.; Li, X. Y. J. Coord. Chem. 2012, 65, 2182.
[14] Ansari, K. F.; Lal, C. Eur. J. Med. Chem. 2009, 44, 4028.
[15] Asthana, S.; Shukla, S.; Vargiu, A. V.; Ceccarelli, M.; Ruggerone, P.; Paglietti, G.; Marongiu, M. E.; Blois, S.; Giliberti, G.; La Colla, P. Biochemistry 2013, 52, 3752.
[16] El-Sherif, A. A. J. Solution Chem. 2010, 39, 1562.
[17] Chou, S. Y.; Yin, W. K.; Chung, Y. S.; Chang, L. S.; Liu, C. W.; Chen, S. F.; Shih, K. S. Org. Process Res. Dev. 2002, 6, 273.
[18] Zheng, Y. C.; Duan, Y. C.; Ma, J. L.; Xu, R. M.; Zi, X.; Lv, W. L.; Wang, M. M.; Ye, X. W.; Zhu, S.; Mobley, D. J. Med. Chem. 2013, 56, 8543.
[19] Ma, L. Y.; Zheng, Y. C.; Wang, S. Q.; Wang, B. J. Med. Chem. 2015, 58, 1705.
[20] Wang, C.; Cao, Q.; Yang, H.; Song, P.; Xue, D.; Cui, F.; Gu, Y.; Zhang, X.; Tian, Y.; Zhang, Q.; Liu, H. Chin. J. Org. Chem. 2016, 36, 1626(in Chinese). (王超杰, 曹钦坡, 杨慧, 宋攀攀, 薛登启, 崔飞, 顾一飞, 张孝松, 田亚楠, 张秋荣, 刘宏民, 有机化学, 2016, 36, 1626.)
[21] Song, P.; Li, N.; Cui, F.; Xin, J.; Zhang, X.; Cao, Q.; Wang, C.; Dai, W.; Meng, X.; Liu, M.; Chang, T.; Liu, Q.; Sun, Y.; Ke, J.; Zhang, Q.; Liu, H. Chin. J. Org. Chem. 2017, 37, 2725(in Chinese). (宋攀攀, 栗娜, 崔飞, 辛景超, 张孝松, 曹钦坡, 王超杰, 戴文杰, 孟祥川, 刘梦, 常通航, 柳晴怡, 孙月红, 可钰, 张秋荣, 刘宏民, 有机化学, 2017, 37, 2725.)
[22] Izsák, D.; Klapötke, T. M.; Pflüger, C. Dalton Trans. 2015, 44, 17054.

文章导航

/